About Cygnus Technologies
Cygnus Technologies is a Healthcare company based in Southport (United States) founded in 2003, and was acquired by Maravai Life Sciences in October 2016. Analytical products for life sciences are manufactured and supplied. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents. Its competitors include GenScript and OriGene; 2 of its 2 listed competitors have raised funding.
Company details
Cygnus Technologies was founded in 2003 and is based in Southport, United States. Specialized analytical products are provided to the pharmaceutical and biotechnology sectors for process development and quality control. The portfolio encompasses ELISA kits, DNA detection tools, Western blot kits, antibodies, immunogenicity analysis, antigen concentrates, and immunoassay reagents. Custom services in antibody production, assay development, and bioprocess support are also offered.
- Headquarters Southport, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website cygnustechnologies.com
- Social LinkedIn X Facebook YouTube
- Acquired by Maravai Life Sciences (Oct 2016)
- Investors
- Acquired byMaravai Life Sciences
(Oct 2016)
Apps and channels of Cygnus Technologies
its YouTube channel Cygnus Technologies has 414 subscribers and 17 videos.
Videos from Cygnus Technologies
The most watched videos on Cygnus Technologies's YouTube channel, Cygnus Technologies (414 subscribers). Click a video to play it here.
More on Cygnus Technologies.
Investors in Cygnus Technologies
Cygnus Technologies has secured backing from 1 investor. Prominent investors backing the company include Maravai Life Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provides enabling tools and services in the life sciences research and bio-production industries | 2014 | maravai.com | San Diego, United States |
Investor details for Cygnus Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cygnus Technologies
21 people are tracked at Cygnus Technologies (4 in leadership, 17 in team).
| Name | Role | Group |
|---|---|---|
David A. Hylander | Director, Manufacturing Operations | Leadership |
Johnathan Locklear | Associate Director, R&d And Technical Services | Leadership |
Ken Hoffman | Founder | Leadership |
Gary Cross | Vice President Operations | Leadership |
Monica Griffith | Senior Associate Scientist | Team |
Christian Pierce | Process Development Specialist | Team |
Maria Papanikolaou | Senior Quality Control Technician | Team |
Vince Boveia | Senior Scientist | Team |
Cindy Rawls | Quality Specialist | Team |
Johanna Barnhill | Senior Associate Scientist | Team |
Carolin Brunner | Quality Control Technician | Team |
Sarah Carroll | Scientist, Research And Development | Team |
Anthony Westgate | Senior Manufacturing Associate Scientist | Team |
Dominique Mitchell | Order Fulfillment Technician | Team |
Larry Tremaglio | Process Engineer | Team |
Tammie Crabtree | Customer Service Manager/ Lab Production Manager | Team |
Colin Conner | Senior Manufacturing Associate Scientist | Team |
Orensi Cela | Scientist | Team |
Norm Snell | Facility Engineer | Team |
Mark Lombard | Technical Business Development Manager | Team |
1 more people are available in the full profile.
Complete people profiles for Cygnus Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cygnus Technologies
2 dated milestones of Cygnus Technologies across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Cygnus Technologies is founded.
- Exit Acquired by Maravai Life Sciences.
Competitors of Cygnus Technologies
Cygnus Technologies has 2 listed competitors in our database, 2 of them funded. They include GenScript and OriGene.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. |
Detailed competitors of Cygnus Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cygnus Technologies
The website of Cygnus Technologies (cygnustechnologies.com) receives about 8K visits a month.
- Monthly visits8K
▲ 12.3% vs previous month
Websites whose visitors overlap most with Cygnus Technologies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
eaglebio.com | eaglebio.com | 100% | #4,012,942 | – | |
arp1.com | arp1.com | 99% | #2,752,384 | – | |
| crystalchem.com | 94% | 4.5K | #4,393,035 | View details | |
| ibl-america.com | 94% | #2,953,589 | View details | ||
| abbexa.com | 90% | #540,549 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Cygnus Technologies
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Cygnus Technologies (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cygnus Technologies
Complete news archive for Cygnus Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cygnus Technologies
Cygnus Technologies was founded in 2003.
Cygnus Technologies is headquartered in Southport, United States. It is registered at Southport, North Carolina, United States.
Cygnus Technologies was founded in 2003 and is based in Southport, United States. Specialized analytical products are provided to the pharmaceutical and biotechnology sectors for process development and quality control. The portfolio encompasses ELISA kits, DNA detection tools, Western blot kits, antibodies, immunogenicity analysis, antigen concentrates, and immunoassay reagents. Custom services in antibody production, assay development, and bioprocess support are also offered.
Cygnus Technologies has 1 investor. Key investors include Maravai Life Sciences.
Yes. Cygnus Technologies was acquired by Maravai Life Sciences in October 2016.